Levels of pro-apoptotic regulator Bad and anti-apoptotic regulator Bcl-xL determine the type of the apoptotic logic gate

BackgroundApoptosis is a tightly regulated process: cellular survive-or-die decisions cannot be accidental and must be unambiguous. Since the suicide program may be initiated in response to numerous stress stimuli, signals transmitted through a number of checkpoints have to be eventually integrated.ResultsIn order to analyze possible mechanisms of the integration of multiple pro-apoptotic signals, we constructed a simple model of the Bcl-2 family regulatory module. The module collects upstream signals and processes them into life-or-death decisions by employing interactions between proteins from three subgroups of the Bcl-2 family: pro-apoptotic multidomain effectors, pro-survival multidomain restrainers, and pro-apoptotic single domain BH3-only proteins. Although the model is based on ordinary differential equations (ODEs), it demonstrates that the Bcl-2 family module behaves akin to a Boolean logic gate of the type dependent on levels of BH3-only proteins (represented by Bad) and restrainers (represented by Bcl-xL). A low level of pro-apoptotic Bad or a high level of pro-survival Bcl-xL implies gate AND, which allows for the initiation of apoptosis only when two stress stimuli are simultaneously present: the rise of the p53 killer level and dephosphorylation of kinase Akt. In turn, a high level of Bad or a low level of Bcl-xL implies gate OR, for which any of these stimuli suffices for apoptosis.ConclusionsOur study sheds light on possible signal integration mechanisms in cells, and spans a bridge between modeling approaches based on ODEs and on Boolean logic. In the proposed scheme, logic gates switching results from the change of relative abundances of interacting proteins in response to signals and involves system bistability. Consequently, the regulatory system may process two analogous inputs into a digital survive-or-die decision.

[1]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[2]  Xin Lu,et al.  Differential induction of transcriptionally active p53 following UV or lonizing radiation: Defects in chromosome instability syndromes? , 1993, Cell.

[3]  C. Thompson,et al.  Apoptosis in the pathogenesis and treatment of disease , 1995, Science.

[4]  S. Korsmeyer,et al.  Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death , 1995, Cell.

[5]  John Calvin Reed,et al.  Tumor suppressor p53 is a direct transcriptional activator of the human bax gene , 1995, Cell.

[6]  J C Reed,et al.  Structure-function analysis of Bcl-2 family proteins. Regulators of programmed cell death. , 1996, Advances in experimental medicine and biology.

[7]  Elizabeth Yang,et al.  Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL , 1996, Cell.

[8]  F Gambale,et al.  Inhibition of Bax channel-forming activity by Bcl-2. , 1997, Science.

[9]  N. Hay,et al.  The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. , 1997, Genes & development.

[10]  G M Cohen,et al.  Caspases: the executioners of apoptosis. , 1997, The Biochemical journal.

[11]  Asim Khwaja,et al.  Matrix adhesion and Ras transformation both activate a phosphoinositide 3‐OH kinase and protein kinase B/Akt cellular survival pathway , 1997, The EMBO journal.

[12]  J Downward,et al.  PKB/Akt: connecting phosphoinositide 3-kinase to cell survival and beyond. , 1997, Trends in biochemical sciences.

[13]  M. Oren,et al.  Mdm2 promotes the rapid degradation of p53 , 1997, Nature.

[14]  M. Fiscella,et al.  Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R E Burke,et al.  Apoptosis in neurodegenerative disorders. , 1997, Current opinion in neurology.

[16]  Colin B. Reese,et al.  3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase , 1997, Current Biology.

[17]  M. Fiscella,et al.  Wip 1 , a novel human protein phosphatase that is induced in response to ionizing radiation in a p 53-dependent manner , 1997 .

[18]  S. Srinivasula,et al.  Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade , 1997, Cell.

[19]  S. R. Datta,et al.  Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery , 1997, Cell.

[20]  David R. Kaplan,et al.  Direct Regulation of the Akt Proto-Oncogene Product by Phosphatidylinositol-3,4-bisphosphate , 1997, Science.

[21]  Yoichi Taya,et al.  DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2 , 1997, Cell.

[22]  D. Lane,et al.  The p53 tumour suppressor gene , 1998, The British journal of surgery.

[23]  Y Taya,et al.  Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. , 1998, Science.

[24]  Sally A Amundson,et al.  Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress , 1998, Oncogene.

[25]  J. Wang,et al.  Cellular responses to DNA damage. , 1998, Current opinion in cell biology.

[26]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[27]  John Calvin Reed.  Dysregulation of apoptosis in cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  David G. Kirsch,et al.  Caspase-3-dependent Cleavage of Bcl-2 Promotes Release of Cytochrome c * , 1999, The Journal of Biological Chemistry.

[29]  D. Green,et al.  Bax-induced Caspase Activation and Apoptosis via Cytochromec Release from Mitochondria Is Inhibitable by Bcl-xL* , 1999, The Journal of Biological Chemistry.

[30]  E. Slee,et al.  Serial killers: ordering caspase activation events in apoptosis , 1999, Cell Death and Differentiation.

[31]  E. Kandel,et al.  The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. , 1999, Experimental cell research.

[32]  Masashi Narita,et al.  Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC , 1999, Nature.

[33]  E. Stavridi,et al.  Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[34]  T. Taniguchi,et al.  Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. , 2000, Science.

[35]  S R Datta,et al.  14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. , 2000, Molecular cell.

[36]  K. Vousden,et al.  PUMA, a novel proapoptotic gene, is induced by p53. , 2001, Molecular cell.

[37]  S. Korsmeyer,et al.  BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. , 2001, Molecular cell.

[38]  T. Mak,et al.  Regulation of PTEN transcription by p53. , 2001, Molecular cell.

[39]  S. Korsmeyer,et al.  Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death , 2001, Science.

[40]  W. Zong,et al.  BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. , 2001, Genes & development.

[41]  Markus Rehm,et al.  Single-cell Fluorescence Resonance Energy Transfer Analysis Demonstrates That Caspase Activation during Apoptosis Is a Rapid Process , 2002, The Journal of Biological Chemistry.

[42]  S. Korsmeyer,et al.  Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. , 2002, Cancer cell.

[43]  K. Imai,et al.  The proapoptotic BH3-only protein BAD transduces cell death signals independently of its interaction with Bcl-2 , 2002, Cell Death and Differentiation.

[44]  Toshiyuki Obata,et al.  Akt Enhances Mdm2-mediated Ubiquitination and Degradation of p53* , 2002, The Journal of Biological Chemistry.

[45]  S. Cory,et al.  The Bcl2 family: regulators of the cellular life-or-death switch , 2002, Nature Reviews Cancer.

[46]  Masashi Narita,et al.  14-3-3 Interacts Directly with and Negatively Regulates Pro-apoptotic Bax* , 2003, The Journal of Biological Chemistry.

[47]  G. Shore,et al.  BCL-2 Selectively Interacts with the BID-induced Open Conformer of BAK, Inhibiting BAK Auto-oligomerization* , 2003, Journal of Biological Chemistry.

[48]  Daniel Isnardon,et al.  TP53INP1s and Homeodomain-interacting Protein Kinase-2 (HIPK2) Are Partners in Regulating p53 Activity* , 2003, Journal of Biological Chemistry.

[49]  Mark H Ellisman,et al.  Bcl-xL overexpression blocks bax-mediated mitochondrial contact site formation and apoptosis in rod photoreceptors of lead-exposed mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[50]  K. Schulze-Osthoff,et al.  Many cuts to ruin: a comprehensive update of caspase substrates , 2003, Cell Death and Differentiation.

[51]  Michael Berger,et al.  Apoptosis - the p53 network , 2003, Journal of Cell Science.

[52]  A. Thorburn,et al.  Death receptor-induced cell killing. , 2004, Cellular signalling.

[53]  Philippe Juin,et al.  The first alpha helix of Bax plays a necessary role in its ligand-induced activation by the BH3-only proteins Bid and PUMA. , 2004, Molecular cell.

[54]  S. Korsmeyer,et al.  Cell Death Critical Control Points , 2004, Cell.

[55]  A. Fersht,et al.  Cooperative binding of tetrameric p53 to DNA. , 2004, Journal of molecular biology.

[56]  B. Hemmings,et al.  Structure, regulation and function of PKB/AKT--a major therapeutic target. , 2004, Biochimica et biophysica acta.

[57]  S. Lowe,et al.  Intrinsic tumour suppression , 2004, Nature.

[58]  T. Kuwana,et al.  BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. , 2005, Molecular cell.

[59]  L. Mayo,et al.  Phosphorylation of Human p53 at Serine 46 Determines Promoter Selection and whether Apoptosis Is Attenuated or Amplified* , 2005, Journal of Biological Chemistry.

[60]  J. Stucki,et al.  Mathematical modeling of the regulation of caspase-3 activation and degradation. , 2005, Journal of theoretical biology.

[61]  Andrea Ciliberto,et al.  Steady States and Oscillations in the p53/Mdm2 Network , 2005, Cell cycle.

[62]  Lin Chen,et al.  Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. , 2005, Genes & development.

[63]  G B Ermentrout,et al.  Bistability in apoptosis: roles of bax, bcl-2, and mitochondrial permeability transition pores. , 2006, Biophysical journal.

[64]  Haian Fu,et al.  Dynamic 14-3-3/client protein interactions integrate survival and apoptotic pathways. , 2006, Seminars in cancer biology.

[65]  C. Scott,et al.  The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. , 2006, Cancer cell.

[66]  S. Armstrong,et al.  Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. , 2006, Cancer cell.

[67]  R. Milo,et al.  Oscillations and variability in the p53 system , 2006, Molecular systems biology.

[68]  S. Korsmeyer,et al.  A stapled BID BH3 helix directly binds and activates BAX. , 2006, Molecular cell.

[69]  Michael Baumann,et al.  Stimulated PI3K-AKT Signaling Mediated through Ligand or Radiation-Induced EGFR Depends Indirectly, but not Directly, on Constitutive K-Ras Activity , 2007, Molecular Cancer Research.

[70]  N. Danial,et al.  BCL-2 Family Proteins: Critical Checkpoints of Apoptotic Cell Death , 2007, Clinical Cancer Research.

[71]  Michael Baumann,et al.  Stimulated PI 3 K-AKT Signaling Mediated through Ligand or Radiation-Induced EGFR Depends Indirectly , but not Directly , on Constitutive KRas Activity , 2007 .

[72]  F. Mancini,et al.  MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis. , 2007, Molecular cell.

[73]  Erinna F. Lee,et al.  Apoptosis Initiated When BH3 Ligands Engage Multiple Bcl-2 Homologs, Not Bax or Bak , 2007, Science.

[74]  S. Elmore.  Apoptosis: A Review of Programmed Cell Death , 2007, Toxicologic pathology.

[75]  S. Cory,et al.  The Bcl-2 apoptotic switch in cancer development and therapy , 2007, Oncogene.

[76]  K. Vousden,et al.  Coping with stress: multiple ways to activate p53 , 2007, Oncogene.

[77]  Tomasz Lipniacki,et al.  Oscillations and bistability in the stochastic model of p53 regulation. , 2008, Journal of theoretical biology.

[78]  Erinna F. Lee,et al.  INAUGURAL ARTICLE by a Recently Elected Academy Member:Apoptosis is triggered when prosurvival Bcl-2 proteins cannot restrain Bax , 2008 .

[79]  Oliver Sawodny,et al.  ON/OFF and Beyond - A Boolean Model of Apoptosis , 2009, PLoS Comput. Biol..

[80]  G Melino,et al.  Ordering of caspases in cells undergoing apoptosis by the intrinsic pathway , 2009, Cell Death and Differentiation.

[81]  Uttam Surana,et al.  Oscillations of the p53-Akt Network: Implications on Cell Survival and Death , 2009, PloS one.

[82]  G. Gores,et al.  Life and death by death receptors , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[83]  Steffen Klamt,et al.  Transforming Boolean models to continuous models: methodology and application to T-cell receptor signaling , 2009, BMC Systems Biology.

[84]  Osamu Takeuchi,et al.  Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. , 2009, Molecular cell.

[85]  T. Lipniacki,et al.  Exploring mechanisms of oscillations in p53 and nuclear factor-B systems. , 2009, IET systems biology.

[86]  T. Lipniacki,et al.  Crosstalk between p53 and nuclear factor-B systems: pro- and anti-apoptotic functions of NF-B. , 2009, IET systems biology.

[87]  Katsuya Ueno,et al.  Arginine methylation of BCL-2 antagonist of cell death (BAD) counteracts its phosphorylation and inactivation by Akt , 2011, Proceedings of the National Academy of Sciences.

[88]  Chengyu Liang,et al.  Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX , 2011, Cell Research.

[89]  Hendrik G. Stunnenberg,et al.  Role of p53 Serine 46 in p53 Target Gene Regulation , 2011, PloS one.

[90]  Galit Lahav,et al.  Stimulus-dependent dynamics of p53 in single cells , 2011, Molecular systems biology.

[91]  Chao Tang,et al.  Decision making of the p53 network: death by integration. , 2011, Journal of theoretical biology.

[92]  Erinna F. Lee,et al.  Mutation to Bax beyond the BH3 Domain Disrupts Interactions with Pro-survival Proteins and Promotes Apoptosis* , 2011, The Journal of Biological Chemistry.

[93]  Wei Wang,et al.  Two-phase dynamics of p53 in the DNA damage response , 2011, Proceedings of the National Academy of Sciences.

[94]  V. Graupner,et al.  Differential regulation of the proapoptotic multidomain protein Bak by p53 and p73 at the promoter level , 2011, Cell Death and Differentiation.

[95]  Nico Tjandra,et al.  Bcl-xL Retrotranslocates Bax from the Mitochondria into the Cytosol , 2011, Cell.

[96]  Jun Li,et al.  A Two-Step Mechanism for Cell Fate Decision by Coordination of Nuclear and Mitochondrial p53 Activities , 2012, PloS one.

[97]  Martyn Amos,et al.  A reconfigurable NAND/NOR genetic logic gate , 2012, BMC Systems Biology.

[98]  Z. Çakır,et al.  The C-terminal helix of Bcl-xL mediates Bax retrotranslocation from the mitochondria , 2012, Cell Death and Differentiation.

[99]  M. Bedford,et al.  Protein arginine methyltransferases and cancer , 2012, Nature Reviews Cancer.

[100]  Erinna F. Lee,et al.  Bax Crystal Structures Reveal How BH3 Domains Activate Bax and Nucleate Its Oligomerization to Induce Apoptosis , 2013, Cell.

[101]  Masashi Narita,et al.  14-3-3 interacts directly with and negatively regulates pro-apoptotic Bax. , 2015, The Journal of Biological Chemistry.